Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    New Help/Information sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label has been standardized, and the previous 'Intervention / Treatment' label and the 'Revision: v3.5.5' note were removed.
    Difference
    0.6%
    Check dated 2026-06-12T13:38:49.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.5.4 to v3.5.5. This appears to be a minor software update and does not change the study content.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small update to the page's revision tag.
    Difference
    0.1%
    Check dated 2026-05-15T05:46:45.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a minor version change to the site display rather than a change to the clinical trial content.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:16.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Medullary thyroid carcinoma is now listed as a condition, and the Genetic and Rare Diseases Information Center has been added to the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:42.000Z thumbnail image

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.